SPDR S&P Pharmaceuticals ETF Rating $41.43 -0.63 (-1.50%) Closing price 06/13/2025 04:10 PM EasternExtended Trading$41.50 +0.06 (+0.16%) As of 06/13/2025 06:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy 2.71Holdings in XPH have an aggregate rating of Moderate Buy based on 373 analyst ratings issued in the past year covering 42 companies (99.6% of the portfolio).XPH Aggregate Price Target$41.43High Prediction$41.43Average Prediction$41.43Low Prediction$41.43Holdings in XPH have an aggregate price target of $41.43 and a range of $41.43 to $41.43 covering 42 companies (99.6% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy19 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 42 XPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.67%CORTCorcept Therapeutics$70.06-1.6%4.6489 of 5 stars3.00$138.25 97.3%5News CoverageInsider Trade5.23%ELANElanco Animal Health$13.82-2.5%1.0247 of 5 stars2.43$15.17 9.7%7Positive News4.15%ZTSZoetis$164.27-2.7%4.6467 of 5 stars3.10$212.75 29.5%10Positive NewsGap Down3.99%RPRXRoyalty Pharma$34.84-1.2%4.7267 of 5 stars3.25$47.33 35.9%4Positive NewsShort Interest ↑3.92%PRGOPerrigo$26.66-2.2%4.5757 of 5 stars2.25$33.00 23.8%4Positive News3.86%PBHPrestige Consumer Healthcare$83.84-1.5%4.1107 of 5 stars2.50$93.33 11.3%6Positive News3.84%VTRSViatris$8.92-1.9%2.542 of 5 stars1.80$10.40 16.6%53.79%JNJJohnson & Johnson$156.90+0.2%4.7646 of 5 stars2.55$170.88 8.9%20Trending News3.66%PFEPfizer$24.51-1.3%4.9739 of 5 stars2.53$29.17 19.0%15Trending NewsAnalyst Revision3.53%LLYEli Lilly and Company$818.56+0.8%4.8345 of 5 stars2.76$1,011.37 23.6%21Trending NewsAnalyst Revision3.52%TARSTarsus Pharmaceuticals$40.89-0.1%1.9166 of 5 stars3.00$66.67 63.0%73.52%AXSMAxsome Therapeutics$104.10-2.0%4.7344 of 5 stars3.06$172.33 65.5%16Trending NewsAnalyst ForecastInsider TradeAnalyst Revision3.29%MRKMerck & Co., Inc.$81.68-0.2%4.9956 of 5 stars2.43$109.19 33.7%21Positive NewsAnalyst Revision3.24%JAZZJazz Pharmaceuticals$108.50-1.6%4.9637 of 5 stars2.92$184.00 69.6%13Analyst Forecast3.22%PCRXPacira BioSciences$24.24-0.9%2.4655 of 5 stars2.33$26.44 9.1%9Positive News3.21%BMYBristol-Myers Squibb$49.71-1.9%4.8032 of 5 stars2.32$58.00 16.7%22Positive NewsAnalyst Revision3.17%HRMYHarmony Biosciences$32.97-1.1%4.7714 of 5 stars3.11$53.00 60.8%9Positive NewsShort Interest ↑Analyst Revision2.57%AMPHAmphastar Pharmaceuticals$25.82-2.3%4.2391 of 5 stars2.25$32.33 25.2%4Positive News2.55%OGNOrganon & Co.$10.03-0.4%4.7787 of 5 stars2.50$18.00 79.6%6Trending News2.32%ARVNArvinas$7.39-2.4%3.8919 of 5 stars2.55$20.29 174.6%22Positive NewsAnalyst RevisionGap Down2.19%EWTXEdgewise Therapeutics$15.29-0.8%2.6638 of 5 stars2.78$39.78 160.2%9Gap Up2.12%SUPNSupernus Pharmaceuticals$32.03-2.3%2.1484 of 5 stars2.33$36.00 12.4%3Positive News2.01%HROWHarrow$30.31-2.7%2.3587 of 5 stars3.00$61.40 102.6%6News CoverageAnalyst ForecastAnalyst RevisionGap Down1.83%COLLCollegium Pharmaceutical$29.18-1.4%3.9911 of 5 stars2.75$43.75 49.9%4Positive NewsInsider Trade1.82%LQDALiquidia$14.10-2.4%3.6945 of 5 stars3.00$26.89 90.7%9Analyst ForecastOptions Volume1.81%ANIPANI Pharmaceuticals$62.56+0.7%4.1609 of 5 stars3.00$80.13 28.1%9Positive News1.73%LGNDLigand Pharmaceuticals$112.50-1.7%4.3856 of 5 stars3.00$146.14 29.9%7News Coverage1.69%INVAInnoviva$21.69+1.4%4.0969 of 5 stars3.00$55.00 153.6%2High Trading Volume1.46%CRMDCorMedix$14.56-2.0%0.5334 of 5 stars3.14$15.00 3.0%7Positive News1.25%AMRXAmneal Pharmaceuticals$7.75-2.6%3.5312 of 5 stars3.00$11.60 49.7%51.23%MNMDMind Medicine (MindMed)$7.17-1.8%1.9168 of 5 stars3.27$25.50 255.6%11Positive NewsAnalyst RevisionGap Down1.11%OCULOcular Therapeutix$8.73-2.5%3.7848 of 5 stars2.88$16.25 86.1%8Positive News1.01%WVEWave Life Sciences$6.95-3.5%4.259 of 5 stars2.92$20.50 195.0%12News CoverageAnalyst ForecastInsider TradeAnalyst RevisionGap Down0.93%XERSXeris Biopharma$4.35-1.6%3.9035 of 5 stars2.83$6.25 43.7%60.88%NUVBNuvation Bio$1.73-4.7%2.9499 of 5 stars3.17$7.83 354.1%6News CoverageAnalyst ForecastHigh Trading Volume0.85%EYPTEyePoint Pharmaceuticals$9.03+1.9%2.1963 of 5 stars3.00$25.38 181.0%9Positive NewsAnalyst RevisionGap Up0.85%EOLSEvolus$9.93-2.5%4.0499 of 5 stars3.00$23.75 139.2%5Insider Trade0.65%PAHCPhibro Animal Health$23.93-2.4%3.843 of 5 stars1.50$20.00 -16.4%4News CoveragePositive News0.59%ELVNEnliven Therapeutics$21.91+11.4%2.464 of 5 stars3.00$37.25 70.0%4News CoverageInsider TradeGap DownHigh Trading Volume0.55%ZVRAZevra Therapeutics$9.13-2.6%2.8565 of 5 stars3.11$22.29 144.1%9Positive NewsAnalyst Revision0.44%ESPREsperion Therapeutics$1.17-2.5%4.0446 of 5 stars2.50$6.25 434.2%6News CoverageAnalyst Revision0.36%OMEROmeros$3.40-4.2%3.6908 of 5 stars2.83$18.00 429.4%6Trending NewsAnalyst ForecastAnalyst RevisionGap Down This page (NYSEARCA:XPH) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XPH Stock Free XPH Stock Alerts